Keyword Analysis & Research: arrakistx
Keyword Research: People who searched arrakistx also searched
Search Results related to arrakistx on Search Engine
Arrakis - Arrakis Therapeutics
This is an example page. It’s different from a blog post because it will stay in one place and will show up in your site navigation (in most themes). Most people start with an About page that introduces them to potential site visitors. It might say something like this: Hi there! I’m a bike messenger […]
DA: 24 PA: 87 MOZ Rank: 37
@ArrakisTx | Twitter
The latest tweets from @ArrakisTx
DA: 47 PA: 7 MOZ Rank: 50
Arrakis Therapeutics (@arrakistx) • Instagram photos and ...
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to millions of patients. arrakistx.com.
DA: 97 PA: 87 MOZ Rank: 8
Arrakis Therapeutics, USA - HBM Partners AG
www.arrakistx.com. HBM contact: Dr Chandra P. Leo. Company status: private. Arrakis is pioneering the discovery of small-molecule medicines that directly bind to and modify the biological function of RNA to treat disease. This new class of medicines, RNA-targeted small molecules (rSMs), can unlock the therapeutic potential of deeply researched ...
DA: 93 PA: 33 MOZ Rank: 65
Arrakis Therapeutics | CipherBio
Founded: 2015 About. Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of small-molecule medicines that directly bind to and modify the biological function of RNA to treat disease.
DA: 64 PA: 83 MOZ Rank: 38
For any questions or comments about SHAPEware, contact Lee Vandivier [email protected] References. Haller A, et al. Folding and ligand recognition of the TPP riboswitch aptamer at single-molecule resolution PNAS. 2013 Mar 12; 110(11): 4188-4193. doi: 10.1073/pnas.1218062110
DA: 11 PA: 80 MOZ Rank: 89
Arrakis Therapeutics Appoints Patrizio Renzetti as Vice ...
For more information, please visit www.arrakistx.com and engage with us on Twitter @ArrakisTx or on LinkedIn. Contacts Media Contact: Kathryn Morris 914-204-6412 [email protected]
DA: 54 PA: 74 MOZ Rank: 53
Arrakis, Roche team up on RNA-targeting drugs in $190M ...
Arrakis Therapeutics has been dodging pharma suitors since its early days, keeping its head down and “politely declining” advances “because we weren’t ready.” Now, the biotech has ...
DA: 22 PA: 70 MOZ Rank: 6